Scarica l'app Stockscreener
0.3615
2.30%
-0.0085
Dopo l'orario di chiusura:
.37
0.0085
+2.35%
Precedente Chiudi:
$0.37
Aprire:
$0.3591
Volume 24 ore:
256.25K
Relative Volume:
0.21
Capitalizzazione di mercato:
$53.28M
Reddito:
-
Utile/perdita netta:
$-54.17M
Rapporto P/E:
-0.9773
EPS:
-0.3699
Flusso di cassa netto:
$-39.34M
1 W Prestazione:
+0.39%
1M Prestazione:
-86.46%
6M Prestazione:
-80.77%
1 anno Prestazione:
-78.35%
Intervallo 1D:
$0.3501
$0.3671
Intervallo di 1 settimana:
$0.3433
$0.3907
Portata 52W:
$0.3433
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Nome
Immutep Limited Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare IMMP vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.3615 | 53.28M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-13 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | Downgrade | Maxim Group | Buy → Hold |
| 2026-03-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | Iniziato | Citizens | Mkt Outperform |
| 2024-05-17 | Iniziato | CapitalOne | Overweight |
| 2023-08-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-07-16 | Ripresa | Maxim Group | Buy |
| 2018-09-28 | Iniziato | B. Riley FBR | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
Mostra tutto
Immutep Limited Adr Borsa (IMMP) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - Sahm
IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
POM IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - Finansavisen
IMMP Investor News: If You Have Suffered Losses in Immutep - GlobeNewswire
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761 - Stock Titan
On Wednesday, there are stocks with unusual volume. Let's take a look. - ChartMill
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immutep Limited (IMMP) And Encourages Investors to Reach Out - accessnewswire.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - FinancialContent
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation – IMMP - FinancialContent
On Tuesday, there are stocks with unusual volume. Let's take a look. - chartmill.com
IMM:ASX AnnouncementChange in substantial holding17 Mar 2026 - Market Index
[6-K] IMMUTEP Ltd Current Report (Foreign Issuer) | IMMP SEC FilingForm 6-K - Stock Titan
Crude Oil Gains Over 1%; VEON Shares Spike Higher - Sahm
Immutep Stock Tanks After Futility Analysis Ends Key Lung Cancer Trial Early - Sahm
This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com
This EverCommerce analyst is no longer bullish; here are top 5 downgrades for Friday - MSN
This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Immutep stock plunges 80% after lung cancer trial halted - Investing.com
Immutep (NASDAQ: IMMP) lands efti licensing deal and funds runway to Q2 2027 - Stock Titan
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Immutep reports positive phase I data for first-in-class autoimmune antibody IMP761 - MSN
Why Immutep Limited (Common Stock) (YP1A) stock is trending on social mediaHealthcare Stock Analysis & Investment Portfolio Recommendations - Bollywood Helpline
Immutep (IMMP) reports positive IMP761 Phase I study update - Stock Titan
Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely - Sahm
Will Immutep Limited Depositary Receipt stock see insider buying2025 Bull vs Bear & Accurate Intraday Trading Signals - Улправда
Why Immutep Limited (YP1B) stock is a strong analyst pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - Улправда
Immutep Limited (IMMP): Firm Reports Positive Data from Trials - Finviz
Ready to Jump After Recent Trade: Beta Bionics Inc (BBNX) - setenews.com
An analyst sees good growth prospects for Immutep Limited ADR (IMMP) - setenews.com
Immutep Limited Announces 2025 AGM with Key Resolutions - MSN
IMMP 20-F highlights: pipeline progress, IFRS results, Nasdaq ADSs - Stock Titan
Immutep Limited Adr Azioni (IMMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):